Gout Complications

Symptoms of Gout

Attacks can often worsen over time if left untreated
By Carol Eustice
Updated on March 08, 2023
Medically reviewed by Anita C. Chandrasekaran, MD
Table of Contents
View All
Table of Contents

Gout is a complex and often debilitating form of arthritis characterized by sudden, severe attacks of pain, swelling, redness, and tenderness in one or more joints. These excruciating episodes arise from the accumulation of excess uric acid in the body, leading to the formation of sharp, needle-like urate crystals within joint spaces. While any joint can be affected, gout most frequently manifests in the metatarsophalangeal joint at the base of the big toe, making it a common initial presentation.

Gout symptoms often strike with an alarming intensity, typically occurring during the night or in the early morning hours, often waking individuals from sleep. The pain can be so excruciating that even the lightest touch, such as the weight of a bedsheet, becomes unbearable. Left unaddressed, these attacks tend to become more frequent and severe over time, progressing through distinct stages and potentially leading to chronic joint damage, deformity, and significant limitations in movement. Early recognition and treating gout are paramount for preventing these long-term complications and preserving overall quality of life.1

Verywell

Frequent Gout Symptoms

The presentation of gout varies considerably depending on the disease stage, often progressing from subtle beginnings to more pronounced and debilitating symptoms over time. Initially, gout attacks might be relatively mild and manageable, yet they invariably intensify with each subsequent flare-up if the underlying condition remains unaddressed. Understanding these distinct stages is therefore essential for comprehending the natural history of the disease and guiding appropriate medical strategies to mitigate its progressive nature, ultimately aiming to prevent chronic joint damage and improve patient outcomes.

Gout progression is typically categorized into three distinct stages, each reflecting the evolving severity of uric acid accumulation and crystal deposition within the body. These stages highlight the critical importance of continuous monitoring and proactive management, as the disease can silently advance even in the apparent absence of acute symptoms. This silent advancement often leads to more profound and debilitating manifestations in later stages, emphasizing that symptom-free periods do not necessarily signify a cure but rather a quiescent phase that requires ongoing medical oversight.

  • Asymptomatic hyperuricemia: This initial stage is characterized solely by elevated levels of uric acid in the bloodstream, without any overt gout symptoms. Despite the absence of pain or inflammation, this phase is crucial because uric acid crystals have already begun to form and deposit silently around various joints and tissues, laying the groundwork for future attacks. Individuals in this phase are often unaware of the impending threat of gout, making early detection through routine blood tests particularly important for at-risk populations to implement preventive strategies.

  • Acute intermittent gout: The next stage, acute intermittent gout, is defined by the occurrence of hallmark, sudden, and excruciating gout attacks that present periodically, interspersed with symptom-free intervals. While the pain experienced during these flares can be agonizing, it typically resolves on its own within days to weeks, leading some individuals to mistakenly believe the condition has disappeared entirely. However, without consistent treatment, these attacks tend to recur with increasing frequency and severity, gradually impacting joint health and diminishing overall quality of life even during the quiescent phases.

  • Chronic tophaceous gout: This represents the most advanced and debilitating stage of gout, typically developing after many years of untreated or inadequately managed hyperuricemia. During this phase, significant quantities of uric acid crystals coalesce to form hard, visible, and often disfiguring deposits called tophi. These chunky deposits accumulate extensively in and around joint spaces, leading to persistent, severe inflammation, irreversible joint destruction, and chronic arthritis symptoms that severely impair mobility and function.

Acute Intermittent Gout

The acute gout attack is characterized by its sudden onset and intensely painful manifestations. Individuals often describe the sensation as being akin to a broken bone, a severe burn, or experiencing the sharp, piercing feeling of being stabbed with glass, underscoring the profound and incapacitating discomfort. This excruciating pain is rapidly accompanied by pronounced joint swelling, noticeable redness (erythema), and significant warmth in the affected area, all direct consequences of the intense inflammation triggered by the deposition of urate crystals.

Beyond the immediate pain and visible inflammation, an acute gout attack often leads to considerable joint stiffness, making any movement excruciatingly difficult and severely limiting daily activities. Systemic symptoms such as a mild fever and generalized fatigue are also common, reflecting the body's comprehensive inflammatory response. Over half of all gout cases primarily involve the metatarsophalangeal joint at the base of the big toe, making it the most common initial site for attacks, likely due to its relatively lower temperature and susceptibility to micro-trauma. However, other common sites of gout symptoms include the foot, knee, ankle, heel, elbow, wrist, and fingers, reflecting the widespread potential for uric acid crystallization.

This photo contains content that some people may find graphic or disturbing.
See Photo
4kodiak / Getty Images

Gout symptoms frequently occur in clusters of attacks, especially when the body’s uric acid levels remain persistently elevated, a condition known as hyperuricemia. The duration of these acute gout flares can vary significantly, ranging from a few intense hours to several weeks, particularly if no effective medication is administered. While the pain often strikes suddenly, its intensity typically escalates rapidly within the initial 12 to 24 hours of an attack before gradually subsiding, demonstrating a characteristic pattern of a swift peak followed by a slower resolution.3

Attacks are notably more prevalent at night or in the early morning hours, a phenomenon attributable to several physiological factors that promote urate crystal formation. One key reason is nighttime dehydration, which can lead to an increased concentration of uric acid in the bloodstream as water loss occurs. Additionally, the slightly lower body temperatures experienced in peripheral joints during sleep promote the crystallization of uric acid within joints, further exacerbating the likelihood and severity of an acute flare during these nocturnal periods.4

Will Gout Go Away by Itelf?

Gout symptoms typically reach their peak severity within the first 24 hours following their onset, during which the pain and inflammation are most intense. Subsequently, the discomfort will gradually begin to resolve, and in many instances, this resolution can occur spontaneously without specific medical treatment, misleading some individuals into believing the condition has completely disappeared.5 However, it is crucial to understand that even if symptoms subside on their own, seeking professional medical evaluation for a proper diagnosis and comprehensive management plan remains vital to prevent future, potentially more severe, attacks and avoid significant long-term complications.

Chronic Tophaceous Gout

Persistent and untreated hyperuricemia can lead to the widespread and extensive formation of tophi, which are hard, palpable deposits of uric acid crystals located beneath the skin and within or around joint spaces. The continuous buildup of these lumpy deposits results in significant erosion of underlying bone and cartilage, culminating in the development of chronic tophaceous gout and persistent arthritis symptoms. Over extended periods, the affected joint can undergo considerable deformation, which severely impairs its normal function and significantly interferes with an individual's mobility and overall movement.6 This advanced stage is characterized by irreversible joint damage and physical limitation.

While most tophi commonly develop in the big toe, around the fingers, or at the tip of the elbow, these nodular formations can theoretically appear practically anywhere in the body where uric acid crystals accumulate. In some severe instances, tophi can even penetrate the skin, leading to the formation of crusty, chalk-like nodules that are both cosmetically disfiguring and prone to infection. Beyond the superficial manifestations, tophi have also been documented to develop in less common locations, including the ears, on the vocal cords, or even along the spine, underscoring the systemic and pervasive nature of untreated chronic gout.

This photo contains content that some people may find graphic or disturbing.
See Photo
DermNet / CC BY-NC-ND

Gout Complications

The impact of gout extends far beyond the musculoskeletal system, with long-term, uncontrolled hyperuricemia posing significant risks to vital organs, particularly the kidneys. The chronic presence of excess uric acid can lead to the formation of uric acid crystals within the kidneys, a serious complication that predisposes individuals to the development of painful kidney stones. These stones can cause severe pain, recurrent urinary tract infections, and, if left untreated, potential long-term kidney damage. In severe cases, individuals with chronic hyperuricemia may develop a life-threatening condition known as acute uric acid nephropathy (AUAN).

Acute uric acid nephropathy (AUAN) is a serious renal complication resulting from extensive uric acid crystal deposition within the kidney tubules, leading to acute kidney impairment and a rapid, significant reduction in renal function. This condition represents a medical emergency requiring immediate attention to prevent irreversible kidney damage. The symptoms of AUAN are varied and depend on the severity of kidney impairment. They may include a noticeable decrease in urine output, the onset of high blood pressure due to fluid retention and kidney dysfunction, and generalized symptoms such as nausea and profound fatigue. Additionally, individuals might experience shortness of breath, anemia, and significant tissue swelling, particularly edema in the lower extremities, indicating fluid overload and impaired kidney function.

In rare but severe instances of AUAN, a unique dermatological sign known as "uremic frost" may appear, where urea excreted in sweat crystallizes on the skin, appearing as a whitish, powdery coating. This sign is indicative of extremely advanced kidney failure. Individuals with pre-existing kidney disease, such as chronic kidney disease or diabetes, are at a significantly heightened risk of developing AUAN, emphasizing the critical need for vigilant management of uric acid levels in this vulnerable population to prevent acute renal crises and preserve kidney function.

Risk Factors for Gout

Several factors can significantly increase an individual's susceptibility to developing gout. Genetic predispositions play a substantial role, meaning you may be more likely to develop gout if you have certain genetic disorders or a family history of the condition. Furthermore, various underlying medical conditions are strongly associated with an elevated risk for gout, including diabetes, chronic kidney disease, and high blood pressure.7 Certain medications can also interfere with uric acid excretion, thereby contributing to its accumulation. Beyond these medical aspects, lifestyle factors such as excessive alcohol consumption, particularly beer and spirits, and a diet rich in purine-containing foods (like red meat and shellfish) are well-established contributors to hyperuricemia and subsequent gout symptoms.

When to See a Healthcare Provider

Not all individuals with elevated uric acid levels will experience progressive gout symptoms or ultimately require urate-lowering therapy.8 However, it is paramount to avoid the misconception that ignoring symptoms or failing to take proactive measures will not lead to significant complications. Unmanaged gout can result in irreversible joint damage and systemic health issues over time. A common pitfall among those with gout is the belief that a prolonged absence of symptoms signifies the disease has spontaneously disappeared. This is a dangerous misconception that can lead to delayed treatment and worsening outcomes.

In reality, unless the underlying cause of persistently high uric acid levels is effectively controlled, often through a combination of medication and significant changes in diet and lifestyle, gout can continue to advance silently. This silent progression means that microscopic urate crystals may still be depositing within joints and tissues, causing damage that may not become apparent until the next severe flare-up occurs. Therefore, consistent medical oversight, even during symptom-free periods, is crucial for preventing long-term complications and preserving joint health.

For comprehensive guidance on discussing your gout symptoms, concerns, and treatment options with a medical professional, utilize our specialized Healthcare Provider Discussion Guide. This invaluable resource is designed to facilitate an informed conversation, helping you ask pertinent questions and ensure you receive the most appropriate and effective care tailored to your individual needs.

Gout Healthcare Provider Discussion Guide

Get our printable guide for your next healthcare provider's appointment to help you ask the right questions.
Download PDF
Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life.
Email Address
Sign Up
You're in!
Thank you, , for signing up.
There was an error. Please try again.

Diagnosis

It is imperative to consult a healthcare provider promptly to establish an accurate gout diagnosis or to comprehensively assess the progression of an existing condition. Timely medical evaluation is crucial not only for initiating appropriate treatment to alleviate acute symptoms but also for developing a long-term management strategy aimed at preventing future attacks and mitigating the risk of chronic complications, including joint damage and kidney issues. Understanding when to seek professional medical attention is a key step in effectively managing gout.

Seeking professional medical evaluation is especially important if this is your first suspected gout attack. Even if the healthcare provider determines that immediate drug therapy is not necessary, you can significantly benefit from guidance on diet and other lifestyle modifications to mitigate the risk of future attacks and manage uric acid levels effectively. Furthermore, if your symptoms do not show signs of improvement after 48 hours of onset, or if they persist for more than a week despite self-care measures, medical consultation is essential. For individuals already undergoing therapy for gout, a lack of improvement or worsening symptoms may indicate that adjustments to your current treatment regimen are needed to achieve better control.

Additionally, the presence of a high fever (exceeding 100.4 degrees F) accompanying a gout attack necessitates immediate medical review. While a mild fever can occasionally occur with a severe gout flare as part of the systemic inflammatory response, a high-grade fever can be a critical sign of a bacterial infection within the joint, a serious and potentially destructive complication known as septic arthritis. Distinguishing between a gout flare and a joint infection requires urgent medical assessment to prevent severe joint damage or systemic illness.

A comprehensive gout diagnosis typically commences with a thorough physical examination of the affected joint and a detailed review of your complete medical history. This includes an assessment of your family history, current medications, dietary habits, and lifestyle factors that might contribute to hyperuricemia. Following this initial clinical assessment, your healthcare provider may order a series of specialized diagnostic tests specifically designed to confirm the presence of gout, evaluate its severity, and, crucially, to exclude other conditions that can mimic its acute symptoms, ensuring an accurate and timely diagnosis.

Among the common laboratory and imaging tests utilized is a synovial fluid analysis, where a sample of fluid from the affected joint is extracted using a sterile needle and examined under a polarizing microscope to definitively identify the characteristic needle-shaped uric acid crystals. Blood tests are also routinely performed to evaluate kidney function, assessing parameters such as creatinine levels and estimating glomerular filtration rate, and to ascertain blood cell counts, which can indicate systemic inflammation or infection. Urine samples may be collected to check for elevated uric acid levels, providing further insight into the body's uric acid metabolism and excretion.

Additionally, various imaging tests may be employed to aid in diagnosis and assess joint health. X-rays, ultrasound, or dual-energy CT scans may be utilized to evaluate bone health, detect joint deformity, or visualize changes within a joint that are characteristic of chronic gout, such as erosions, bone spurs, or the presence of tophi that might not be visible on a standard physical examination. These imaging modalities provide valuable structural information and can help monitor disease progression over time.

These comprehensive diagnostic evaluations are critical not only for definitively confirming gout but also for meticulously distinguishing it from other conditions with similar clinical presentations. Conditions such as pseudogout, characterized by calcium pyrophosphate crystal deposition, septic arthritis,9 a bacterial infection of the joint, and various other more common types of arthritis can be mistaken for gout. An accurate differential diagnosis ensures that individuals receive the correct and most effective treatment, preventing unnecessary or inappropriate interventions and guiding optimal patient care.

Frequently Asked Questions

  • What does gout look like?
    Gout typically manifests as a joint that is markedly swollen, intensely red, and exceptionally tender to the touch. In the most common site, the metatarsal-phalangeal joint at the base of the big toe, the affected area can appear as a prominent lump, often resembling a bunion, but with a characteristic bright red hue and a distinct feeling of warmth due to severe inflammation.

  • What does gout pain feel like?
    Gout pain is renowned for its sudden onset and extreme severity. Patients frequently describe it as an agonizing sensation, often likening it to a broken bone, the piercing sensation of being stabbed directly in the joint, or a severe burning agony. While most commonly affecting the big toe, this excruciating pain can also impact the knees, ankles, heels, other parts of the feet, elbows, wrists, or fingers. The pain usually intensifies dramatically during the first 24 hours of an attack before gradually subsiding.

  • How long does a gout attack last?
    A gout flare-up can range significantly in duration, from as brief as a few hours to as prolonged as several weeks, depending on its severity and whether treatment is initiated. Attacks are observed to be more probable during the night or in the early morning hours. Generally, the initial 36 hours of a gout attack are characterized by the most intense pain and inflammation, after which the discomfort gradually diminishes.

Read more:

9 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

  1. Igel TF, Krasnokutsky S, Pillinger MH. Recent advances in understanding and managing gout. F1000Res. 2017;6:247. doi:10.12688/f1000research.9402.1
  2. Stewart S, Dalbeth N, Vandal AC, Rome K. The first metatarsophalangeal joint in gout: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2016;17:69. doi:10.1186/s12891-016-0919-9
  3. Centers for Disease Control and Prevention. Gout.
  4. Choi HK, Niu J, Neogi T, et al. Nocturnal risk of gout attacks. Arthritis Rheumatol. 2015;67(2):555-62. doi:10.1002/art.38917
  5. Johns Hopkins Arthritis Center. Symptoms and diagnosis of gout.
  6. Ragab G, Elshahaly M, Bardin T. Gout: An old disease in new perspective - A review. J Adv Res. 2017;8(5):495-511. doi:10.1016/j.jare.2017.04.008
  7. Pagidipati NJ, Clare RM, Keenan RT, Chiswell K, Roe MT, Hess CN. Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease. J Am Heart Assoc. 2018;7(16):e009328. doi:10.1161/JAHA.118.009328
  8. Khanna PP, Gladue HS, Singh MK, et al. Treatment of acute gout: a systematic review. Semin Arthritis Rheum. 2014;44(1):31-8. doi:10.1016/j.semarthrit.2014.02.003
  9. Colaco C, Dotel R. Coexisting polyarticular septic arthritis, gout and pseudogout. BMJ Case Rep; 2018

Additional Reading